{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:42:36Z","timestamp":1784054556881,"version":"3.55.0"},"reference-count":25,"publisher":"Japanese Society of Hypertension","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2007]]},"DOI":"10.1291\/hypres.30.85","type":"journal-article","created":{"date-parts":[[2007,4,27]],"date-time":"2007-04-27T01:10:19Z","timestamp":1177636219000},"page":"85-91","source":"Crossref","is-referenced-by-count":16,"title":["Gene Delivery of Paraoxonase-1 Inhibits Neointimal Hyperplasia after Arterial Balloon-Injury in Rabbits Fed a High-Fat Diet"],"prefix":"10.1291","volume":"30","author":[{"given":"Miwa","family":"MIYOSHI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"NAKANO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takemasa","family":"SAKAGUCHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"OGI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"ODA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"SUENARI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"KIYOTANI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"OZONO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"OSHIMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"YOSHIDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"CHAYAMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. James RW, Deakin SP: The importance of high density lipoproteins for paraoxonase 1 secretion, stability, and activity. Free Radic Biol Med<\/i> 2004; 37<\/b>: 1986-1994.","DOI":"10.1016\/j.freeradbiomed.2004.08.012"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Durrington PN, Mackness B, Mackness MI: Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol<\/i> 2001; 21<\/b>: 473-480.","DOI":"10.1161\/01.ATV.21.4.473"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1996.0401"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1038\/28406"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Rozenberg O, Rosenblat M, Coleman R, Shih DM, Aviram M: Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. Free Radic Biol Med<\/i> 2003; 34<\/b>: 774-784.","DOI":"10.1016\/S0891-5849(02)01429-6"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M910376199"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Rozenberga O, Shiha DM, Aviruma M: Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies PON1 transfected cells and in PON1 transgenic mice. Atherosclerosis<\/i> 2005; 181<\/b>: 9-18.","DOI":"10.1016\/j.atherosclerosis.2004.12.030"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Shih DM, Gu L, Hama S, Xia YR, Navab M: Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model. J Clin Invest<\/i> 1996; 97<\/b>: 1630-1639.","DOI":"10.1172\/JCI118589"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ikeda Y, Suehiro T, Inoue M, Nakauchi Y, Morita T, Arii K: Serum paraoxonase activity and its relationship to diabetic complications in patients with non−insulin-dependent diabetes mellitus. Metabolism<\/i> 1998; 47<\/b>: 598-602.","DOI":"10.1016\/S0026-0495(98)90246-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Paragh G, Balla P, Katona E, Seres I, Egerhazi A, Degrell I: Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia. Eur Arch Psychiatry Clin Neurosci<\/i> 2002; 252<\/b>: 63-67.","DOI":"10.1007\/s004060200013"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Paragh G, Asztalos L, Seres I, et al<\/i>: Serum paraoxonase activity changes in uremic and kidney-transplanted patients. Nephron<\/i> 1999; 83<\/b>: 126-131.","DOI":"10.1159\/000045489"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mackness MI, Durrington PN, Mackness B: The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention. Am J Cardiovasc Drugs<\/i> 2004; 4<\/b>: 211-217.","DOI":"10.2165\/00129784-200404040-00002"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Deakin S, Leviev I, Guernier S, James RW: Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: a role for sterol regulatory element−binding protein-2. Arterioscler Thromb Vasc Biol<\/i> 2003; 23<\/b>: 2083-2089.","DOI":"10.1161\/01.ATV.0000096207.01487.36"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0502677102"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.9960"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nga CJ, Diana B, Shiha M: The paraoxonase gene family and atherosclerosis. Free Radic Biol Med<\/i> 2005; 38<\/b>: 153-163.","DOI":"10.1016\/j.freeradbiomed.2004.09.035"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Watson AD, Berliner JA, Hama SY, et al<\/i>: Protective effect of high density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest<\/i> 1995; 96<\/b>: 2882-2891.","DOI":"10.1172\/JCI118359"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kita T, Kume N, Minami M, Hayashida K: Role of oxidized LDL in atherosclerosis. Ann NY Acad Sci<\/i> 2001; 947<\/b>: 199-205.","DOI":"10.1111\/j.1749-6632.2001.tb03941.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kume N, Murase T, Masaki T, Kita T: Inducible expression of lectin-like oxidized low density lipoprotein receptor-1 in vascular endothelial cells. Circ Res<\/i> 1998; 83<\/b>: 322-327.","DOI":"10.1161\/01.RES.83.3.322"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Li D, Mehta JL: Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol<\/i> 2000; 20<\/b>: 1116-11122.","DOI":"10.1161\/01.ATV.20.4.1116"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tanigawa H, Miura S, Matsuo Y, Fujino M: Dominant-negative lox-1 blocks homodimerization of wild-type lox-1−induced cell proliferation through extracellular signal regulated kinase 1\/2 activation. Hypertension<\/i> 2006; 48<\/b>: 294-300.","DOI":"10.1161\/01.HYP.0000229825.98545.5e"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Vohra RS, Murphy JE, Walker JH, Ponnambalam S, Homer-Vanniasinkam S: Atherosclerosis and the lectin-like oxidized low-density lipoprotein scavenger receptor. Trends Cardiovasc Med<\/i> 2006; 16<\/b>: 60-64.","DOI":"10.1016\/j.tcm.2005.12.001"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Li D, Liu L, Chen H: LOX-1 mediates oxidized low-density lipoprotein−induced expression of matrix metalloproteinases in human coronary artery endothelial cells. Circulation<\/i> 2003; 107<\/b>: 612-617.","DOI":"10.1161\/01.CIR.0000047276.52039.FB"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Negre-Salvayre A, Vieira O, Escargueil-Blanc I: Oxidized LDL and 4-hydroxynonenal modulate tyrosine kinase receptor activity. Mol Aspects Med<\/i> 2003; 24<\/b>: 251-261.","DOI":"10.1016\/S0098-2997(03)00020-7"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1016\/S0098-2997(03)00023-2"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T10:45:36Z","timestamp":1556361936000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nature.com\/doifinder\/10.1291\/hypres.30.85"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1291\/hypres.30.85","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007]]}}}